OSR Health, Inc. (OSRHW) Cash & Equivalents (2023 - 2026)

OSR Health (OSRHW) has 4 years of Cash & Equivalents data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 1.82% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 1.82% YoY), and the FY2025 full-year result was $1.7 million, up 397.82% from the prior year.
• Cash & Equivalents eased to $1.6 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $70.6 million in Q1 2023 to a low of $3637.0 in Q1 2024.
• A 4-year average of $7.2 million and a median of $1.6 million in 2026 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents sank 99.99% in 2024 and surged 43773.99% in 2025, its largest moves.
• Tracing OSRHW's Cash & Equivalents over 4 years: stood at $15419.0 in 2023, then soared by 2115.08% to $341543.0 in 2024, then jumped by 397.82% to $1.7 million in 2025, then decreased by 7.86% to $1.6 million in 2026.
• Business Quant data shows OSRHW's Cash & Equivalents at $1.6 million in Q1 2026, $1.7 million in Q4 2025, and $2.2 million in Q3 2025.